Viridian Therapeutics Stock (NASDAQ: VRDN) stock price, news, charts, stock research, profile.
Open | $13.500 |
Close | $12.880 |
Volume / Avg. | 801.612K / 915.545K |
Day Range | 12.730 - 13.550 |
52 Wk Range | 10.925 - 28.350 |
Market Cap | $822.033M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 36 |
Short Interest | 17.14% |
Days to Cover | 11.55 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Viridian Therapeutics (NASDAQ: VRDN) through any online brokerage.
Other companies in Viridian Therapeutics’s space includes: Immunome (NASDAQ:IMNM), ARS Pharmaceuticals (NASDAQ:SPRY), 89bio (NASDAQ:ETNB), Humacyte (NASDAQ:HUMA) and Zentalis Pharma (NASDAQ:ZNTL).
The latest price target for Viridian Therapeutics (NASDAQ: VRDN) was reported by HC Wainwright & Co. on Thursday, May 9, 2024. The analyst firm set a price target for 27.00 expecting VRDN to rise to within 12 months (a possible 109.63% upside). 35 analyst firms have reported ratings in the last year.
The stock price for Viridian Therapeutics (NASDAQ: VRDN) is $12.88 last updated May 21, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Viridian Therapeutics.
Viridian Therapeutics’s Q2 earnings are confirmed for Tuesday, August 6, 2024.
There is no upcoming split for Viridian Therapeutics.
Viridian Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.